ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

URGN UroGen Pharma Ltd

12,49
-0,48 (-3,70%)
Dernière mise à jour : 16:52:50
Retardé de 15 minutes
Quarter End Mar 2022Juin 2022Sept 2022Déc 2022Mar 2023Juin 2023Sept 2023Déc 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 13,56M16,6M16,1M18,09M17,19M21,14M20,85M23,53M
Revenu d'exploitation -21,96M-18,72M-18,09M-20,28M-22,05M-15,38M-13,5M-14,61M
Revenu avant impôt -28,07M-26,66M-25,12M-28,18M-30,19M-24,08M-21,89M-22,16M
Revenu net -28,39M-26,69M-25,83M-28,87M-30,21M-24,14M-21,88M-26,02M
Dividendes privilégiés 00000000
Résultat de base par action 00000000
EBIT -21,96M-18,62M-18,05M-20,35M-22,06M-15,41M-13,47M-13,8M
EBITDA -21,74M-18,48M-17,85M-20,05M-21,83M-15,17M-13,31M-14,42M
Fin d'année 31 Décembre 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 17,53M8,16M1,13M18k11,8M48,04M64,36M82,71M
Revenu d'exploitation 798k-19,95M-77,18M-109,48M-126,74M-92,29M-79,04M-65,54M
Revenu avant impôt -1,94M-19,98M-75,53M-105,15M-125,11M-109,37M-108,03M-98,32M
Revenu net -1,94M-20M-75,66M-105,15M-128,48M-110,82M-109,78M-102,24M
Dividendes privilégiés 00000000
Résultat de base par action -0.259-1.056-3.534-4.01-4.696-4.007-3.876-2.835
EBIT 798k-19,95M-77,3M-109,76M-126,74M-92,29M-78,97M-64,7M
EBITDA 1,01M-19,74M-76,76M-109,18M-126,32M-91,46M-78,12M-64,73M

Dernières Valeurs Consultées

Delayed Upgrade Clock